Drug recall · June 17, 2015
Alprostadil recall
Why: Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Alprostadil (PFE1), solution, 30 mcg/mL, injectable, 5 mL vial, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT
- Lots / codes
Lot 04062015:18@1. Expiry date: 8/1/2015
- Quantity
- 1/5 mL vial
- Company
- Montana Compounding Pharmacy, Missoula, MT
- Distribution
- MT and ND
- Initiated
- May 15, 2015 · Voluntary: Firm initiated
- Classified
- June 9, 2015
- Reported
- June 17, 2015
- Ended
- December 20, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Alprostadil
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.